These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22173290)

  • 1. Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma.
    Baumhoer D; Smida J; Zillmer S; Rosemann M; Atkinson MJ; Nelson PJ; Jundt G; von Luettichau I; Nathrath M
    Mod Pathol; 2012 Apr; 25(4):522-8. PubMed ID: 22173290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice.
    Brennecke P; Arlt MJ; Muff R; Campanile C; Gvozdenovic A; Husmann K; Holzwarth N; Cameroni E; Ehrensperger F; Thelen M; Born W; Fuchs B
    PLoS One; 2013; 8(9):e74045. PubMed ID: 24040160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinoma.
    Clatot F; Cornic M; Berghian A; Marchand V; Choussy O; El Ouakif F; François A; Ruminy P; Laberge-Le-Couteulx S; Picquenot JM; Jardin F
    Pathology; 2015 Jan; 47(1):45-50. PubMed ID: 25474514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the CXCL12-CXCR4/CXCR7 axis in the progression and metastasis of bone sarcomas (Review).
    Liao YX; Zhou CH; Zeng H; Zuo DQ; Wang ZY; Yin F; Hua YQ; Cai ZD
    Int J Mol Med; 2013 Dec; 32(6):1239-46. PubMed ID: 24127013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma.
    Dumars C; Ngyuen JM; Gaultier A; Lanel R; Corradini N; Gouin F; Heymann D; Heymann MF
    Oncotarget; 2016 Nov; 7(48):78343-78354. PubMed ID: 27823976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.
    D'Alterio C; Avallone A; Tatangelo F; Delrio P; Pecori B; Cella L; Pelella A; D'Armiento FP; Carlomagno C; Bianco F; Silvestro L; Pacelli R; Napolitano M; Iaffaioli RV; Scala S
    Int J Cancer; 2014 Jul; 135(2):379-90. PubMed ID: 24375277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis.
    Moreno MJ; Gallardo A; Novelli S; Mozos A; Aragó M; Pavón MÁ; Céspedes MV; Pallarès V; Falgàs A; Alcoceba M; Blanco O; Gonzalez-Díaz M; Sierra J; Mangues R; Casanova I
    PLoS One; 2018; 13(6):e0198789. PubMed ID: 29920526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.
    Sun X; Cheng G; Hao M; Zheng J; Zhou X; Zhang J; Taichman RS; Pienta KJ; Wang J
    Cancer Metastasis Rev; 2010 Dec; 29(4):709-22. PubMed ID: 20839032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients.
    Sand LG; Scotlandi K; Berghuis D; Snaar-Jagalska BE; Picci P; Schmidt T; Szuhai K; Hogendoorn PC
    Eur J Cancer; 2015 Nov; 51(17):2624-33. PubMed ID: 26428435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.
    Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD
    Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
    Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
    PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.
    Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y
    Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
    Werner TA; Forster CM; Dizdar L; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A
    Br J Cancer; 2017 Dec; 117(12):1837-1845. PubMed ID: 29112684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12, CXCR4 and CXCR7 expression in brain metastases.
    Salmaggi A; Maderna E; Calatozzolo C; Gaviani P; Canazza A; Milanesi I; Silvani A; DiMeco F; Carbone A; Pollo B
    Cancer Biol Ther; 2009 Sep; 8(17):1608-14. PubMed ID: 19625779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.